NuCana plc (NCNA)
$1.08-1.82%Close
SELLCRISIS · day 8
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $7M
- Beta
- 2.31
- P/E (TTM)
- -0.28
- Short % float
- 1.75%
- Days to cover
- 1.0
- SI change
- -6.7%
- 1W
- +1.89%
- 1M
- -18.18%
- vs SPY 1W
- +1.46%
- vs SPY 1M
- -20.24%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on NCNA?
- LOPJLB’s latest quantitative signal on NuCana plc (NCNA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is NCNA in?
- NuCana plc (NCNA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does NuCana plc (NCNA) do?
- NuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering advanced therapies for oncology. Its innovative product pipeline is underpinned by a proprietary ProTide technology platform. Among its key drug candidates, Acelarin is progressing through multiple clinical evaluations: a Phase I study for advanced solid tumors, Phase Ib trials for both recurrent ovarian cancer and bi…